Biogen

Biogen products

Alprolix®

• Generic: coagulation Factor IX (recombinant), Fc fusion protein

• Indication: control and prevention of bleeding episodes, perioperative management, and prophylaxis in adults and children with hemophilia B

Avonex®

• Generic: interferon beta-1a

• Indication: relapsing forms of multiple sclerosis (MS)

Ampyra® (also referred via Fampyra)

• Generic: dalfampridine (prolonged-release fampridine)

• Indication: improves walking ability in patients with MS

Eloctate®

• Generic: antihemophilic Factor VIII (recombinant), Fc fusion protein

• Indication: control and prevention of bleeding, perioperative management, and prophylaxis in adults and children with hemophilia A

Fampyra®

• Generic: fampridine prolonged-release tablets

• Indication: walking improvement in MS patients

Gazyva®

• Generic: obinutuzumab

• Indication: chronic lymphocytic leukemia

Leqembi®

• Generic: lecanemab-irmb

• Indication: early Alzheimer’s disease (mild cognitive impairment or mild dementia)

• Forms: intravenous and newly FDA-approved subcutaneous (at-home) autoinjector (Leqembi Iqlik™)

Plegridy®

• Generic: peginterferon beta-1a

• Indication: relapsing forms of MS

Qalsody®

• Generic: tofersen

• Indication: ALS associated with SOD1 mutation; administered as intrathecal injection

Rituxan®

• Generic: rituximab

• Indication: non-Hodgkin lymphoma, RA, ANCA-associated vasculitis

Spinraza®

• Generic: nusinersen

• Indication: spinal muscular atrophy (SMA)

Tecfidera®

• Generic: dimethyl fumarate

• Indication: relapsing forms of MS

Tysabri®

• Generic: natalizumab

• Indication: relapsing-remitting MS

Vumerity®

• Generic: diroximel fumarate

• Indication: relapsing forms of MS

Skyclarys®

• Generic: omaveloxolone

• Indication: Friedreich’s ataxia (FDA-approved)

Zurzuvae®

• Generic: zuranolone

• Indication: postpartum depression (FDA-approved)